SlideShare a Scribd company logo
RHEUMATOLOGICAL
MANIFESTATIONS OF SYSTEMIC
DISEASES
Dr Vinay C
Moderator: Dr Sajjan Shenoy, Rhematologist, KMC
Introduction
Rheumatic manifestations of DM are the commonest of all described
endocrine rheumatic manifestations.
 Under-recognized and poorly treated.
These not only involve joints, but also the soft tissues and the bones.
 Closely linked to age, disease duration, vascular complications and
glycemic control.
In contrast to various vascular complications of diabetes mellitus
(DM) that are life threatening, rheumatic manifestations lead to
considerable morbidity.
Disorder which represents intrinsic complications of diabetes which
include
a. Diabetic muscle infarction (common in type 1 diabetes mellitus).
b. Neuropathic arthropathy which include charcot joint, claw toe, roker
bottom sole.
Disorder related to metabolic derangement
i. DISH
ii. Osteopenia
iii. Osteoporosis
b. Disorders which share similar aetiological mechanism as with
microvascular disease and change of collagen
i. Limited joint mobility (Chieroarthropathy)
ii. Dupuytren’s contracture
iii. Palmar flexor tenosynovitis (trigger finger)
iv. Adhesive capsulitis of the shoulder
v. Sudeks dystrophy.
Other rheumatological disorders which are common in general
population have increased prevalence in diabetic population
a. Carpal tunnel syndrome
b. Gout
c. Osteoarthritis
d. Osteolysis of fore foot
e. Migratory osteolysis of hip and knee
Cheiroarthropathy
Also called has stiff hand syndrome/ Limited joints mobility
syndrome.
It is characterized by thick, tight, waxy skin mainly on the
dorsal aspect of the hands, with flexion deformities of the
1. metacarpo-phalangeal and
2. interphalangeal joints
Pathogenesis: Dermal and subcutaneous sclerosis secondary
to non-enzymatic glycation of collagen with decreased
collagen degradation.
Limited joint mobility can be shown clinically by the inability
of the two palms to come completely together, with the wrists
maximally flexed, forming the prayer sign .
 In the early stages, paraesthesias and slight pain develop.
The symptoms increase very slowly, and greater pain,
aggravated by movement of the hands.
prayer sign
Table top sign
 Biopsy specimens - thickening of periarticular rather than
articular collagen, due to non-enzymatic glycosylation of
collagen.
Commonly seen in type 1 diabetics and is a marker of other
diabetic vascular complications.
Limited joint mobility and Dupuytren’s contracture are
commonly found in the same patient.
Treatment includes NSAIDS, Physiotherapy and better
glcemic control.
DUPUYTREN’S CONTRACTURE
It present with thickening, shortening, fibrosis and nodule formation
of the palmar fascia.
Result in flexion contractures of the fingers.
In patients with diabetes, the ring and middle finger are more
commonly affected, compared with the fifth finger in patients
without diabetes.
 The prevalence of Dupuytren’s contracture in diabetic patients
ranges from 20 to 63%, compared with 13% in the general
population.
The contractures are generally milder in diabetics than in patients
with Dupuytren’s contracture who do not have diabetes.
Rx consist of physiotherapy, steroid injections, and Surgical
intervention in some severe cases.
Carpel Tunnel Syndrome
Otherwise called as entrapment neuropathy
Characterized by pain and paraesthesia over the median nerve
cutaneous distribution of the thumb, index, middle, and lateral half of
the ring fingers, which is often worse at night.
The symptoms caused by compression of the median nerve within
the carpal tunnel as well as diabetic neuropathy, or a combination of
both
About 20% of patients with CTS have diabetes.
 Tinel sign: percussion of nerve triggers pain resembling elecric
shock.
 Phalen sign: palmar flexion for 30 sec causes paraesthesias.
 it is more common in women than in men.
Treatment:
simple analgesics, splints, local steroid injections
Surgery is indicated in those patients who fail the above
conservative measures.
Trigger finger
Flexor tenosynovitis (trigger finger or stenosing tenovaginitis) is
caused by fibrous tissue proliferation in the tendon sheath leading to
limitation of the normal movement of the tendon.
Middle and index finger most commonly involved.
Patients complains of a "catching" or "locking" sensation that may be
associated with pain in the affected fingers.
Examination shows a palpable nodule and thickening along the
affected flexor tendon sheath, overlying palmar aspect of the
metacarpophalangeal joint.
Flexor tenosynovitis is associated with the duration of diabetes but
not age.
A corticosteroid injection into the symptomatic flexor tendon sheath
is often curative.
other treatment modalities are NSAIDS, splinting, surgical release.
Complex regional pain syndrome
Formerly called Reflex sympathetic dystrophy or shoulder-hand
syndrome(Sudek’s atrophy).
Characterized by localised or diffuse pain, usually with associated
swelling, trophic changes, and vasomotor disturbances, with impaired
mobility of the affected region.
The condition may occur spontaneously, or after minimal trauma—
following surgery or a fracture.
 Concurrent medical conditions may predispose to reflex
sympathetic dystrophy, including :
Diabetes mellitus
 Hyperthyroidism
Hyperparathyroidism
Type IV hyperlipidaemia.
Treatment includes corticostroids, muscle relaxants, intavenous
sympathetic blockade
surgical symphathectomy, physiotherapy.
Adhesive Capsulitis
Adhesive capsulitis/frozen shoulder, seen twice as common in
diabetic patients.
It refers to a stiffened glenohumeral joint, usually caused by
thickening and contraction of the joint capsule which results in a
substantial decrease in capsular volume capacity.
Patients report shoulder stiffness, along with decreased range of
motion and pain.
The pain of this conditions is less in DM than that of the general
population , also be seen in hyperthyroidism, Addison disease, and
parkinsonism.
The decreased range of motion is worst in abduction and external
rotation.
Internal rotation is affected least.
Treatment is mainly conservative involves physiotherapy, use of
analgesic, steroids ,Surgical and arthroscopic capsular release.
Diffuse idiopathic skeletal hyperostosis
Commonly seen in Type 2 DM
characterized by excessive bone growth and calcification of
paraspinal ligaments, due to hyperostosis effect of
hyperinsulinaemia (osteoblast stimulation and osteoclast inhibition).
New bone formation,mostly involving thoracolumbar vertebrae, as
well as calcification of spinal ligaments.
Degree of glycemic control does not correlate with incidence or
progression of the symptoms.
Usually presents with
contiguous thoracic vertebral segments, typically described as
flowing osteophytes along the anterolateral aspects of those four
vertebrae
preservation of intervertebral disc spaces
absence of apophyseal joint degeneration
absence sacroiliac inflammatory changes.
 Ossification of ligaments and tendons elsewhere may occur, such
as the skull, pelvis, heels, or elbows.
 A proposed mechanism of causation is the prolonged and high
levels of insulin or insulin-like growth factors occurring in diabetic
patients, stimulating new bone.
 mild stiffness on arising in the morning, and 16% of affected
persons may develop dysphagia.
Treatment :
analgesics, heat application , physiotheraphy and glycemic control.
Charcot neuroarthropathy
 Progressive, non infectious disease seen in persons with sensory
neuropathy
 Diabetes is the most common cause of charcot neuroarthopathy.
 It causes severe destruction of joints, particularly in the feet.
 Theories :
 Neurotraumatic theory proposes that loss of neuroprotection leads
to repetitive micro trauma.
 Neurotrophic theory:
sympathetic neuropathy catalyses osteoclast bone resorption and
fragmentation.
Treatment : Early immobilisation, Bisphosphonates,
Splinting/bracing to protect the area from weight bearing to avoid
further damage and good glycemic control.
Diabetic muscle infarction
 Also called as Tumoriform focal muscular degeneration
 Common in type 1 DM with mean duration of 15 years.
 Acute onset of muscle pain and swelling. Most commonly
effecting thigh muscles and calf muscles. A palpable mass has been
reported in 34-44%.
 muscle biopsy: muscle fibre necrosis, edema, granulation tissue.
Serum creatine kinase levels elevated
 medical treatment : anti platelet and anti inflammatory drugs.
Other rarer associations
Osteopenia
Osteoporosis
Osteoarthritis
Gout
conclusion
The identification of characteristic rheumatologic manifestations of
diabetes early may facilitate its management.
 On the other hand, presence of rheumatic manifestations in a
diabetic patient can serve as a marker for poor glycemic control and
presence of micro vascular complications like diabetic retinopathy.
References
1)Brawn DL, McCrae FC, Show KM. Musculoskeletal disease in diabetes.
Practical Diabetes International 2001;18(2):62-4.
(2)BJ Van Rensburg, Contextualizing musculoskeletal complications of
Diabetes Mellitus. SARJ Vol1.No4
(3)Behrman: Nelson Textbook of Pediatrics, 17th ed. p1947. Elsevier
2004.
(4) Veijola R, Reijonen H, Vahasalo P, Sabbah E, Kulmala P, Ilonen J,
Akerblom JK, Knim M. The childhood diabetes in Finland study group.
HLADQB1-definined genetic susceptibility, [beta]-cell autoimmunity, and
metabolic characteristics in familial and nonfamilial insulin-dependent
diabetes mellitus. 1996. J Clin Invest 98: 2489-2495.

More Related Content

What's hot

Rheumatic Disorders Part I
Rheumatic Disorders Part IRheumatic Disorders Part I
Rheumatic Disorders Part I
Carmela Domocmat
 
Musculoskeletal Disorders in Diabetes Mellitus
Musculoskeletal Disorders in Diabetes MellitusMusculoskeletal Disorders in Diabetes Mellitus
Musculoskeletal Disorders in Diabetes Mellitus
Hamid R. Fateh, MD
 
ra-2013-final.pptx
ra-2013-final.pptxra-2013-final.pptx
ra-2013-final.pptx
AbdelrahmanElBady1
 
Scleroderma - Dhara
Scleroderma - Dhara Scleroderma - Dhara
Scleroderma - Dhara
Rivindu Wickramanayake
 
Musculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitusMusculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitus
fathi neana
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Vignesvararajah Lokeesan
 
Gout
GoutGout
Rhematoid arthiritis
Rhematoid arthiritisRhematoid arthiritis
Rhematoid arthiritis
jasleenbrar03
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
sameera.moparty
 
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07finIdiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
MedicineAndHealthNeurolog
 
Psoriatic arthritis
Psoriatic arthritis Psoriatic arthritis
Psoriatic arthritis
Dinoosh De Livera
 
Diagnostic approach to musculoskeletal pain
Diagnostic approach to musculoskeletal painDiagnostic approach to musculoskeletal pain
Diagnostic approach to musculoskeletal pain
Rachmat Gunadi Wachjudi
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
Hirdesh Chawla
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Amer
 
Mixed Connective Tissue Disorders.ppt
Mixed Connective Tissue Disorders.pptMixed Connective Tissue Disorders.ppt
Mixed Connective Tissue Disorders.ppt
Shama
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Doha Rasheedy
 
Approach to and recent advances in management of rheumatoid arthritis
Approach to and recent advances in management of rheumatoid arthritisApproach to and recent advances in management of rheumatoid arthritis
Approach to and recent advances in management of rheumatoid arthritis
Chetan Ganteppanavar
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
keerthi samuel
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
Mansoura University Hospitals
 
Rheumatic Disorders Part IV
Rheumatic Disorders Part IVRheumatic Disorders Part IV
Rheumatic Disorders Part IV
Carmela Domocmat
 

What's hot (20)

Rheumatic Disorders Part I
Rheumatic Disorders Part IRheumatic Disorders Part I
Rheumatic Disorders Part I
 
Musculoskeletal Disorders in Diabetes Mellitus
Musculoskeletal Disorders in Diabetes MellitusMusculoskeletal Disorders in Diabetes Mellitus
Musculoskeletal Disorders in Diabetes Mellitus
 
ra-2013-final.pptx
ra-2013-final.pptxra-2013-final.pptx
ra-2013-final.pptx
 
Scleroderma - Dhara
Scleroderma - Dhara Scleroderma - Dhara
Scleroderma - Dhara
 
Musculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitusMusculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitus
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Gout
GoutGout
Gout
 
Rhematoid arthiritis
Rhematoid arthiritisRhematoid arthiritis
Rhematoid arthiritis
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07finIdiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
Idiopathic Inflammator Myopathie Dr.Mark Boulos June5 07fin
 
Psoriatic arthritis
Psoriatic arthritis Psoriatic arthritis
Psoriatic arthritis
 
Diagnostic approach to musculoskeletal pain
Diagnostic approach to musculoskeletal painDiagnostic approach to musculoskeletal pain
Diagnostic approach to musculoskeletal pain
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Mixed Connective Tissue Disorders.ppt
Mixed Connective Tissue Disorders.pptMixed Connective Tissue Disorders.ppt
Mixed Connective Tissue Disorders.ppt
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Approach to and recent advances in management of rheumatoid arthritis
Approach to and recent advances in management of rheumatoid arthritisApproach to and recent advances in management of rheumatoid arthritis
Approach to and recent advances in management of rheumatoid arthritis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Psoriatic arthritis
Psoriatic arthritisPsoriatic arthritis
Psoriatic arthritis
 
Rheumatic Disorders Part IV
Rheumatic Disorders Part IVRheumatic Disorders Part IV
Rheumatic Disorders Part IV
 

Viewers also liked

1 gastrointestinal manifestations of systemic sclerosis
1 gastrointestinal manifestations of systemic sclerosis1 gastrointestinal manifestations of systemic sclerosis
1 gastrointestinal manifestations of systemic sclerosis
maushard
 
Treatment of diffuse systemic sclerosis with AIMSPRO
Treatment of diffuse systemic sclerosis with AIMSPROTreatment of diffuse systemic sclerosis with AIMSPRO
Treatment of diffuse systemic sclerosis with AIMSPRO
Aimspro - Daval International Ltd
 
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MDCardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
maushard
 
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
Scleroderma & Raynaud's UK (SRUK)
 
Raynaud's phenomenon
Raynaud's  phenomenonRaynaud's  phenomenon
Raynaud's phenomenon
zahra seraji
 
Scleroderma
SclerodermaScleroderma
Scleroderma
hodmedicine
 
What is Raynaud's, what is scleroderma?
What is Raynaud's, what is scleroderma?What is Raynaud's, what is scleroderma?
What is Raynaud's, what is scleroderma?
Scleroderma & Raynaud's UK (SRUK)
 
Sleroderma
SlerodermaSleroderma
Sleroderma
Ariyanto Harsono
 
Raynaud’s phenomenon
Raynaud’s phenomenonRaynaud’s phenomenon
Raynaud’s phenomenon
Fardan Qadeer
 
Morphea
MorpheaMorphea
Morphea
IRu Wu
 
Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation
Suneth Weerarathna
 
Ss dr kim
Ss dr kimSs dr kim
Ss dr kim
maushard
 
Scleroderma in children and young people
Scleroderma in children and young peopleScleroderma in children and young people
Scleroderma in children and young people
Scleroderma & Raynaud's UK (SRUK)
 
Raynaud
RaynaudRaynaud
Progresive systemic sclerosis
Progresive systemic sclerosisProgresive systemic sclerosis
Progresive systemic sclerosis
Chitralekha Khati
 
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
maushard
 
Scleroderma
SclerodermaScleroderma
Scleroderma
drmomusa
 
Systemic sclerosis
Systemic sclerosisSystemic sclerosis
Systemic sclerosis
TEENA MARY JAMES
 
Clinical evaluation of the patient with rheumatic disease
Clinical evaluation of the patient with rheumatic diseaseClinical evaluation of the patient with rheumatic disease
Clinical evaluation of the patient with rheumatic disease
Faculty of Medicine, Ain Shams University
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseases
katejohnpunag
 

Viewers also liked (20)

1 gastrointestinal manifestations of systemic sclerosis
1 gastrointestinal manifestations of systemic sclerosis1 gastrointestinal manifestations of systemic sclerosis
1 gastrointestinal manifestations of systemic sclerosis
 
Treatment of diffuse systemic sclerosis with AIMSPRO
Treatment of diffuse systemic sclerosis with AIMSPROTreatment of diffuse systemic sclerosis with AIMSPRO
Treatment of diffuse systemic sclerosis with AIMSPRO
 
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MDCardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
Cardiovascular Manifestations, Systemic Sclerosis by Dr. Jonathan R. Lindner MD
 
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
Raynaud’s phenomenon in systemic sclerosis: Why do the blood vessels stop wor...
 
Raynaud's phenomenon
Raynaud's  phenomenonRaynaud's  phenomenon
Raynaud's phenomenon
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
What is Raynaud's, what is scleroderma?
What is Raynaud's, what is scleroderma?What is Raynaud's, what is scleroderma?
What is Raynaud's, what is scleroderma?
 
Sleroderma
SlerodermaSleroderma
Sleroderma
 
Raynaud’s phenomenon
Raynaud’s phenomenonRaynaud’s phenomenon
Raynaud’s phenomenon
 
Morphea
MorpheaMorphea
Morphea
 
Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation
 
Ss dr kim
Ss dr kimSs dr kim
Ss dr kim
 
Scleroderma in children and young people
Scleroderma in children and young peopleScleroderma in children and young people
Scleroderma in children and young people
 
Raynaud
RaynaudRaynaud
Raynaud
 
Progresive systemic sclerosis
Progresive systemic sclerosisProgresive systemic sclerosis
Progresive systemic sclerosis
 
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
Skin Manifestations of Scleroderma, by Dr. Lorinda Chung MD
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Systemic sclerosis
Systemic sclerosisSystemic sclerosis
Systemic sclerosis
 
Clinical evaluation of the patient with rheumatic disease
Clinical evaluation of the patient with rheumatic diseaseClinical evaluation of the patient with rheumatic disease
Clinical evaluation of the patient with rheumatic disease
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseases
 

Similar to rheumatological manifestations of systemic diseases- diabetes

Musculo skeletal complication of diabetes mellitus
Musculo skeletal complication of diabetes mellitusMusculo skeletal complication of diabetes mellitus
Musculo skeletal complication of diabetes mellitus
AminuArzet
 
Diabetes and rheumatic diseases (nx power lite)
Diabetes and rheumatic diseases (nx power lite)Diabetes and rheumatic diseases (nx power lite)
Diabetes and rheumatic diseases (nx power lite)
adel311
 
Musculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitusMusculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitus
Patnaik Gourishankar
 
diabetesmellitus-141029144107-conversion-gate01 2.pptx
diabetesmellitus-141029144107-conversion-gate01 2.pptxdiabetesmellitus-141029144107-conversion-gate01 2.pptx
diabetesmellitus-141029144107-conversion-gate01 2.pptx
abhimittal8
 
Rheumatic Manifestations in Diabetes Mellitus Patients
Rheumatic Manifestations in Diabetes Mellitus PatientsRheumatic Manifestations in Diabetes Mellitus Patients
Rheumatic Manifestations in Diabetes Mellitus Patients
Apollo Hospitals
 
DM_and_MS_new.pptx
DM_and_MS_new.pptxDM_and_MS_new.pptx
DM_and_MS_new.pptx
hhhaaa787878
 
Arthritides
ArthritidesArthritides
Arthritides
Pierre Lopez
 
rheumatoid arthritis details ins and outs
rheumatoid arthritis details ins and outsrheumatoid arthritis details ins and outs
rheumatoid arthritis details ins and outs
Bosan Khalid
 
Diabetes - Musculoskeletal Complication
Diabetes - Musculoskeletal ComplicationDiabetes - Musculoskeletal Complication
Diabetes - Musculoskeletal Complication
Dr. Mohit Goel
 
Dm msk compl.
Dm msk compl.Dm msk compl.
Dm msk compl.
Anish Choudhary
 
4441564759967.pptx
4441564759967.pptx4441564759967.pptx
4441564759967.pptx
biruktesfaye27
 
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
abdelrazekdawod
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritis
Koppala RVS Chaitanya
 
14-180530185343.pdf
14-180530185343.pdf14-180530185343.pdf
14-180530185343.pdf
Bucky10
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
yuyuricci
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Arthiritis and related Diseases-1.pptx
Arthiritis and related Diseases-1.pptxArthiritis and related Diseases-1.pptx
Arthiritis and related Diseases-1.pptx
Ashu Bansal
 
Arthropathy in haematological disorders in children
Arthropathy in haematological disorders in childrenArthropathy in haematological disorders in children
Arthropathy in haematological disorders in children
dattasrisaila
 
Seropositive arthritis ppt
Seropositive arthritis pptSeropositive arthritis ppt
Seropositive arthritis ppt
Saurabh Chahar
 
Diabetic Foot Ulcer.pptx
Diabetic Foot Ulcer.pptxDiabetic Foot Ulcer.pptx
Diabetic Foot Ulcer.pptx
GaniDwiCahya2
 

Similar to rheumatological manifestations of systemic diseases- diabetes (20)

Musculo skeletal complication of diabetes mellitus
Musculo skeletal complication of diabetes mellitusMusculo skeletal complication of diabetes mellitus
Musculo skeletal complication of diabetes mellitus
 
Diabetes and rheumatic diseases (nx power lite)
Diabetes and rheumatic diseases (nx power lite)Diabetes and rheumatic diseases (nx power lite)
Diabetes and rheumatic diseases (nx power lite)
 
Musculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitusMusculoskeletal manifestations of diabetes mellitus
Musculoskeletal manifestations of diabetes mellitus
 
diabetesmellitus-141029144107-conversion-gate01 2.pptx
diabetesmellitus-141029144107-conversion-gate01 2.pptxdiabetesmellitus-141029144107-conversion-gate01 2.pptx
diabetesmellitus-141029144107-conversion-gate01 2.pptx
 
Rheumatic Manifestations in Diabetes Mellitus Patients
Rheumatic Manifestations in Diabetes Mellitus PatientsRheumatic Manifestations in Diabetes Mellitus Patients
Rheumatic Manifestations in Diabetes Mellitus Patients
 
DM_and_MS_new.pptx
DM_and_MS_new.pptxDM_and_MS_new.pptx
DM_and_MS_new.pptx
 
Arthritides
ArthritidesArthritides
Arthritides
 
rheumatoid arthritis details ins and outs
rheumatoid arthritis details ins and outsrheumatoid arthritis details ins and outs
rheumatoid arthritis details ins and outs
 
Diabetes - Musculoskeletal Complication
Diabetes - Musculoskeletal ComplicationDiabetes - Musculoskeletal Complication
Diabetes - Musculoskeletal Complication
 
Dm msk compl.
Dm msk compl.Dm msk compl.
Dm msk compl.
 
4441564759967.pptx
4441564759967.pptx4441564759967.pptx
4441564759967.pptx
 
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
Differential diagnosis of musculoskeletal involvement in rheumatoid arthritis...
 
Pharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritisPharmacotherapy of Rheumatoid arthritis
Pharmacotherapy of Rheumatoid arthritis
 
14-180530185343.pdf
14-180530185343.pdf14-180530185343.pdf
14-180530185343.pdf
 
Rheumatoid Arthritis
Rheumatoid ArthritisRheumatoid Arthritis
Rheumatoid Arthritis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Arthiritis and related Diseases-1.pptx
Arthiritis and related Diseases-1.pptxArthiritis and related Diseases-1.pptx
Arthiritis and related Diseases-1.pptx
 
Arthropathy in haematological disorders in children
Arthropathy in haematological disorders in childrenArthropathy in haematological disorders in children
Arthropathy in haematological disorders in children
 
Seropositive arthritis ppt
Seropositive arthritis pptSeropositive arthritis ppt
Seropositive arthritis ppt
 
Diabetic Foot Ulcer.pptx
Diabetic Foot Ulcer.pptxDiabetic Foot Ulcer.pptx
Diabetic Foot Ulcer.pptx
 

Recently uploaded

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

rheumatological manifestations of systemic diseases- diabetes

  • 1. RHEUMATOLOGICAL MANIFESTATIONS OF SYSTEMIC DISEASES Dr Vinay C Moderator: Dr Sajjan Shenoy, Rhematologist, KMC
  • 2. Introduction Rheumatic manifestations of DM are the commonest of all described endocrine rheumatic manifestations.  Under-recognized and poorly treated. These not only involve joints, but also the soft tissues and the bones.  Closely linked to age, disease duration, vascular complications and glycemic control.
  • 3. In contrast to various vascular complications of diabetes mellitus (DM) that are life threatening, rheumatic manifestations lead to considerable morbidity.
  • 4.
  • 5. Disorder which represents intrinsic complications of diabetes which include a. Diabetic muscle infarction (common in type 1 diabetes mellitus). b. Neuropathic arthropathy which include charcot joint, claw toe, roker bottom sole.
  • 6. Disorder related to metabolic derangement i. DISH ii. Osteopenia iii. Osteoporosis
  • 7. b. Disorders which share similar aetiological mechanism as with microvascular disease and change of collagen i. Limited joint mobility (Chieroarthropathy) ii. Dupuytren’s contracture iii. Palmar flexor tenosynovitis (trigger finger) iv. Adhesive capsulitis of the shoulder v. Sudeks dystrophy.
  • 8. Other rheumatological disorders which are common in general population have increased prevalence in diabetic population a. Carpal tunnel syndrome b. Gout c. Osteoarthritis d. Osteolysis of fore foot e. Migratory osteolysis of hip and knee
  • 9.
  • 10.
  • 11. Cheiroarthropathy Also called has stiff hand syndrome/ Limited joints mobility syndrome. It is characterized by thick, tight, waxy skin mainly on the dorsal aspect of the hands, with flexion deformities of the 1. metacarpo-phalangeal and 2. interphalangeal joints Pathogenesis: Dermal and subcutaneous sclerosis secondary to non-enzymatic glycation of collagen with decreased collagen degradation.
  • 12. Limited joint mobility can be shown clinically by the inability of the two palms to come completely together, with the wrists maximally flexed, forming the prayer sign .  In the early stages, paraesthesias and slight pain develop. The symptoms increase very slowly, and greater pain, aggravated by movement of the hands.
  • 15.  Biopsy specimens - thickening of periarticular rather than articular collagen, due to non-enzymatic glycosylation of collagen. Commonly seen in type 1 diabetics and is a marker of other diabetic vascular complications. Limited joint mobility and Dupuytren’s contracture are commonly found in the same patient. Treatment includes NSAIDS, Physiotherapy and better glcemic control.
  • 16. DUPUYTREN’S CONTRACTURE It present with thickening, shortening, fibrosis and nodule formation of the palmar fascia. Result in flexion contractures of the fingers. In patients with diabetes, the ring and middle finger are more commonly affected, compared with the fifth finger in patients without diabetes.  The prevalence of Dupuytren’s contracture in diabetic patients ranges from 20 to 63%, compared with 13% in the general population.
  • 17. The contractures are generally milder in diabetics than in patients with Dupuytren’s contracture who do not have diabetes. Rx consist of physiotherapy, steroid injections, and Surgical intervention in some severe cases.
  • 18.
  • 19. Carpel Tunnel Syndrome Otherwise called as entrapment neuropathy Characterized by pain and paraesthesia over the median nerve cutaneous distribution of the thumb, index, middle, and lateral half of the ring fingers, which is often worse at night. The symptoms caused by compression of the median nerve within the carpal tunnel as well as diabetic neuropathy, or a combination of both About 20% of patients with CTS have diabetes.
  • 20.  Tinel sign: percussion of nerve triggers pain resembling elecric shock.  Phalen sign: palmar flexion for 30 sec causes paraesthesias.  it is more common in women than in men. Treatment: simple analgesics, splints, local steroid injections Surgery is indicated in those patients who fail the above conservative measures.
  • 21. Trigger finger Flexor tenosynovitis (trigger finger or stenosing tenovaginitis) is caused by fibrous tissue proliferation in the tendon sheath leading to limitation of the normal movement of the tendon. Middle and index finger most commonly involved. Patients complains of a "catching" or "locking" sensation that may be associated with pain in the affected fingers. Examination shows a palpable nodule and thickening along the affected flexor tendon sheath, overlying palmar aspect of the metacarpophalangeal joint.
  • 22. Flexor tenosynovitis is associated with the duration of diabetes but not age. A corticosteroid injection into the symptomatic flexor tendon sheath is often curative. other treatment modalities are NSAIDS, splinting, surgical release.
  • 23.
  • 24. Complex regional pain syndrome Formerly called Reflex sympathetic dystrophy or shoulder-hand syndrome(Sudek’s atrophy). Characterized by localised or diffuse pain, usually with associated swelling, trophic changes, and vasomotor disturbances, with impaired mobility of the affected region. The condition may occur spontaneously, or after minimal trauma— following surgery or a fracture.
  • 25.  Concurrent medical conditions may predispose to reflex sympathetic dystrophy, including : Diabetes mellitus  Hyperthyroidism Hyperparathyroidism Type IV hyperlipidaemia.
  • 26.
  • 27. Treatment includes corticostroids, muscle relaxants, intavenous sympathetic blockade surgical symphathectomy, physiotherapy.
  • 28. Adhesive Capsulitis Adhesive capsulitis/frozen shoulder, seen twice as common in diabetic patients. It refers to a stiffened glenohumeral joint, usually caused by thickening and contraction of the joint capsule which results in a substantial decrease in capsular volume capacity. Patients report shoulder stiffness, along with decreased range of motion and pain. The pain of this conditions is less in DM than that of the general population , also be seen in hyperthyroidism, Addison disease, and parkinsonism.
  • 29.
  • 30. The decreased range of motion is worst in abduction and external rotation. Internal rotation is affected least. Treatment is mainly conservative involves physiotherapy, use of analgesic, steroids ,Surgical and arthroscopic capsular release.
  • 31. Diffuse idiopathic skeletal hyperostosis Commonly seen in Type 2 DM characterized by excessive bone growth and calcification of paraspinal ligaments, due to hyperostosis effect of hyperinsulinaemia (osteoblast stimulation and osteoclast inhibition). New bone formation,mostly involving thoracolumbar vertebrae, as well as calcification of spinal ligaments. Degree of glycemic control does not correlate with incidence or progression of the symptoms.
  • 32. Usually presents with contiguous thoracic vertebral segments, typically described as flowing osteophytes along the anterolateral aspects of those four vertebrae preservation of intervertebral disc spaces absence of apophyseal joint degeneration absence sacroiliac inflammatory changes.
  • 33.
  • 34.
  • 35.  Ossification of ligaments and tendons elsewhere may occur, such as the skull, pelvis, heels, or elbows.  A proposed mechanism of causation is the prolonged and high levels of insulin or insulin-like growth factors occurring in diabetic patients, stimulating new bone.  mild stiffness on arising in the morning, and 16% of affected persons may develop dysphagia. Treatment : analgesics, heat application , physiotheraphy and glycemic control.
  • 36. Charcot neuroarthropathy  Progressive, non infectious disease seen in persons with sensory neuropathy  Diabetes is the most common cause of charcot neuroarthopathy.  It causes severe destruction of joints, particularly in the feet.  Theories :  Neurotraumatic theory proposes that loss of neuroprotection leads to repetitive micro trauma.
  • 37.  Neurotrophic theory: sympathetic neuropathy catalyses osteoclast bone resorption and fragmentation. Treatment : Early immobilisation, Bisphosphonates, Splinting/bracing to protect the area from weight bearing to avoid further damage and good glycemic control.
  • 38. Diabetic muscle infarction  Also called as Tumoriform focal muscular degeneration  Common in type 1 DM with mean duration of 15 years.  Acute onset of muscle pain and swelling. Most commonly effecting thigh muscles and calf muscles. A palpable mass has been reported in 34-44%.  muscle biopsy: muscle fibre necrosis, edema, granulation tissue. Serum creatine kinase levels elevated  medical treatment : anti platelet and anti inflammatory drugs.
  • 40. conclusion The identification of characteristic rheumatologic manifestations of diabetes early may facilitate its management.  On the other hand, presence of rheumatic manifestations in a diabetic patient can serve as a marker for poor glycemic control and presence of micro vascular complications like diabetic retinopathy.
  • 41. References 1)Brawn DL, McCrae FC, Show KM. Musculoskeletal disease in diabetes. Practical Diabetes International 2001;18(2):62-4. (2)BJ Van Rensburg, Contextualizing musculoskeletal complications of Diabetes Mellitus. SARJ Vol1.No4 (3)Behrman: Nelson Textbook of Pediatrics, 17th ed. p1947. Elsevier 2004. (4) Veijola R, Reijonen H, Vahasalo P, Sabbah E, Kulmala P, Ilonen J, Akerblom JK, Knim M. The childhood diabetes in Finland study group. HLADQB1-definined genetic susceptibility, [beta]-cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. 1996. J Clin Invest 98: 2489-2495.